NCT00499850View on ClinicalTrials.gov

Phase I FOLFOX Combination

PHASE1CompletedINTERVENTIONAL
Enrollment

18

Participants

Timeline

Start Date

August 31, 2005

Primary Completion Date

June 30, 2006

Study Completion Date

April 30, 2008

Conditions
Advanced Colorectal Carcinoma
Interventions
DRUG

ZD6474 (vandetanib)

once daily oral dose

DRUG

5-Fluorouracil

intravenous infusion

DRUG

Leucovorin

intravenous infusion

DRUG

Oxaliplatin

intravenous infusion

Trial Locations (4)

Unknown

Research Site, East Melbourne

Research Site, Footscray

Research Site, Heidelberg

Research Site, Parkville

All Listed Sponsors
lead

Genzyme, a Sanofi Company

INDUSTRY

NCT00499850 - Phase I FOLFOX Combination | Biotech Hunter | Biotech Hunter